Hematopoietic Tumors in a Mouse Model of X-linked Chronic Granulomatous Disease after Lentiviral Vector-Mediated Gene Therapy.


Journal

Molecular therapy : the journal of the American Society of Gene Therapy
ISSN: 1525-0024
Titre abrégé: Mol Ther
Pays: United States
ID NLM: 100890581

Informations de publication

Date de publication:
06 01 2021
Historique:
received: 10 04 2020
revised: 03 08 2020
accepted: 20 09 2020
pubmed: 4 10 2020
medline: 1 10 2021
entrez: 3 10 2020
Statut: ppublish

Résumé

Chronic granulomatous disease (CGD) is a rare inherited disorder due to loss-of-function mutations in genes encoding the NADPH oxidase subunits. Hematopoietic stem and progenitor cell (HSPC) gene therapy (GT) using regulated lentiviral vectors (LVs) has emerged as a promising therapeutic option for CGD patients. We performed non-clinical Good Laboratory Practice (GLP) and laboratory-grade studies to assess the safety and genotoxicity of LV targeting myeloid-specific Gp91

Identifiants

pubmed: 33010230
pii: S1525-0016(20)30487-1
doi: 10.1016/j.ymthe.2020.09.030
pmc: PMC7791081
pii:
doi:

Substances chimiques

NADPH Oxidase 2 EC 1.6.3.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

86-102

Informations de copyright

Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Références

Clin Infect Dis. 2015 Apr 15;60(8):1176-83
pubmed: 25537876
Curr Gene Ther. 2015;15(4):416-27
pubmed: 25981636
Gene Ther. 2011 Nov;18(11):1087-97
pubmed: 21544095
Nat Rev Drug Discov. 2019 Jun;18(6):447-462
pubmed: 30858502
Mol Ther. 2014 Aug;22(8):1472-1483
pubmed: 24869932
Expert Rev Clin Immunol. 2013 Feb;9(2):153-60
pubmed: 23390946
Lancet. 2014 Feb 1;383(9915):436-48
pubmed: 24161820
J Virol. 1998 Dec;72(12):9873-80
pubmed: 9811723
Lancet. 2016 Jul 30;388(10043):476-87
pubmed: 27289174
JAMA. 2015 Apr 21;313(15):1550-63
pubmed: 25898053
Radiat Res. 2000 May;153(5 Pt 2):627-36
pubmed: 10790285
Mol Ther. 2009 Nov;17(11):1919-28
pubmed: 19672245
N Engl J Med. 2009 Jan 29;360(5):447-58
pubmed: 19179314
Nat Med. 2006 Apr;12(4):401-9
pubmed: 16582916
Blood. 2010 Jan 28;115(4):783-91
pubmed: 19965657
Mol Ther. 2016 Oct;24(10):1873-1880
pubmed: 27456061
BMC Bioinformatics. 2017 Nov 25;18(1):520
pubmed: 29178837
J Cell Biol. 1983 Jul;97(1):52-61
pubmed: 6408102
Mol Ther. 2011 Jan;19(1):122-32
pubmed: 20978475
Mol Ther. 2011 Nov;19(11):2092-101
pubmed: 21878903
Blood. 2016 Jul 21;128(3):440-8
pubmed: 27216217
J Clin Invest. 1990 Mar;85(3):821-35
pubmed: 2312727
Blood. 2009 Sep 24;114(13):2619-22
pubmed: 19541821
Nat Med. 2010 Feb;16(2):198-204
pubmed: 20098431
Blood. 2011 May 19;117(20):5332-9
pubmed: 21403130
Lancet Haematol. 2019 May;6(5):e239-e253
pubmed: 30981783
Blood. 2016 Jul 7;128(1):45-54
pubmed: 27129325
Bioinformatics. 2012 Mar 15;28(6):755-62
pubmed: 22238265
Science. 2013 Aug 23;341(6148):1233151
pubmed: 23845947
Nat Methods. 2007 Dec;4(12):1051-7
pubmed: 18049469
Blood. 2005 Dec 1;106(12):3932-9
pubmed: 16109773
J Pediatric Infect Dis Soc. 2018 May 9;7(suppl_1):S2-S5
pubmed: 29746675
N Engl J Med. 2019 Apr 18;380(16):1525-1534
pubmed: 30995372
Science. 2013 Aug 23;341(6148):1233158
pubmed: 23845948
Nat Med. 2020 Feb;26(2):200-206
pubmed: 31988463
Mol Ther. 2006 Aug;14(2):218-25
pubmed: 16647883
Cancer Res. 1971 Dec;31(12):2133-42
pubmed: 4330444
Blood. 2011 Mar 17;117(11):3113-22
pubmed: 21228324
Proc Natl Acad Sci U S A. 1997 Oct 28;94(22):12133-8
pubmed: 9342375
Blood. 2019 Jun 6;133(23):2546-2549
pubmed: 30952673
Nat Biotechnol. 2010 May;28(5):495-501
pubmed: 20436461
Hum Gene Ther Clin Dev. 2018 Jun;29(2):69-79
pubmed: 29664709
Exp Toxicol Pathol. 2006 Jul;57(5-6):377-81
pubmed: 16713211
J Allergy Clin Immunol. 2016 Jul;138(1):219-228.e9
pubmed: 26853280
Blood. 1997 May 15;89(10):3503-21
pubmed: 9160655
Nat Genet. 2000 Jun;25(2):217-22
pubmed: 10835641
Nat Biotechnol. 2006 Jun;24(6):687-96
pubmed: 16732270
Genome Med. 2014 Jun 27;6(6):46
pubmed: 25028597
Free Radic Biol Med. 1994 Feb;16(2):149-56
pubmed: 8005510
Hum Gene Ther. 2007 Sep;18(9):821-36
pubmed: 17845130
J Clin Invest. 2017 May 1;127(5):1689-1699
pubmed: 28346229
Acta Haematol. 2003;110(2-3):86-92
pubmed: 14583668

Auteurs

Raisa Jofra Hernández (R)

San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy; GLP Test Facility, San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Andrea Calabria (A)

San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Francesca Sanvito (F)

GLP Test Facility, San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy; Pathology Unit, Department of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Fabiola De Mattia (F)

San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Giada Farinelli (G)

San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Serena Scala (S)

San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Ilaria Visigalli (I)

GLP Test Facility, San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Nicola Carriglio (N)

GLP Test Facility, San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Maura De Simone (M)

GLP Test Facility, San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Michela Vezzoli (M)

GLP Test Facility, San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Francesca Cecere (F)

GLP Test Facility, San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Maddalena Migliavacca (M)

San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy; Pediatric Immunohematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Luca Basso-Ricci (L)

San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Maryam Omrani (M)

San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Fabrizio Benedicenti (F)

San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Rossana Norata (R)

GLP Test Facility, San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Paola Maria Vittoria Rancoita (PMV)

University Centre for Statistics in the Biomedical Sciences, Vita-Salute San Raffaele University, Milan, Italy.

Clelia Di Serio (C)

University Centre for Statistics in the Biomedical Sciences, Vita-Salute San Raffaele University, Milan, Italy.

Paola Albertini (P)

GLP Test Facility, San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Patrizia Cristofori (P)

GLP Test Facility, San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy; Non-Clinical Safety In Vivo Translation Research, Glaxo Smith Kline, Ware, UK.

Luigi Naldini (L)

San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy; Medical School, Vita-Salute San Raffaele University, Milan, Italy.

Bernhard Gentner (B)

San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy; Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Eugenio Montini (E)

San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Alessandro Aiuti (A)

San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy; Pediatric Immunohematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy; Medical School, Vita-Salute San Raffaele University, Milan, Italy. Electronic address: aiuti.alessandro@hsr.it.

Alessandra Mortellaro (A)

San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH